// App-Quantinova.ai

2582 : Assessment of ?H2AX levels in circulating tumor cells in patients treated with veliparib in combination with doxorubicin and cyclophosphamide in metastatic breast cancer.

Researchers

Presenter

  • Antoinette R. Tan

Principal Investigators

  • Deborah Toppmeyer

  • Serena Tsan-Lai Wong

  • Hongxia Lin

  • Murugesan Gounder

  • Rebecca Anne Moss

  • Mark N. Stein

  • Janice M. Mehnert

  • Sinae Kim

  • Alice P. Chen

  • Robert S. DiPaola

Medical Centers

  • National Cancer Institute, Bethesda, MD

  • Rutgers Cancer Institute of New Jersey, New Brunswick, NJ

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Doxorubicin

  • Veliparib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT00740805

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved